Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULARStandard

LUPRON DEPOT-PED KIT

LEUPROLIDE ACETATE

Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LUPRON DEPOT-PED KIT is listed in Drugs@FDA under application 020263 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEUPROLIDE ACETATE Form and strength POWDER;INTRAMUSCULAR - 15MG Sponsor ABBVIE ENDOCRINE INC Submission history Latest submission status date: 2025-11-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview LUPRON DEPOT-PED KIT is listed in Drugs@FDA under application 020263 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEUPROLIDE ACETATE Form and strength POWDER;INTRAMUSCULAR - 15MG Sponsor ABBVIE ENDOCRINE INC Submission history Latest submission status date: 2025-11-14 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.